In an in vitro setting, NSCLC adenocarcinoma H1299 cell line was used as a mean of identifying signalling pathways, which - upon activation by INSL4 overexpression - might affect cell growth and drug responsiveness. The gene discussed is INSL4; the disease is non-small cell lung carcinoma.